PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424343
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424343
The Global Platelet Concentration Systems Market size is expected to reach US$ 838.4 Mn by 2030, from US$ 424.9 Mn in 2023, at a CAGR of 10.2% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023/2024: | US$ 424.9 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 10.20% | 2030/2031 Value Projection: | US$ 838.4 Mn |
Platelet concentration systems are pivotal medical devices that are used for concentrating platelets collected from donor's blood. The platelet-rich plasma or PRP derived from these systems contain a higher density of platelets than normal blood. PRP is defined as plasma with an elevated platelet concentration over that of normal plasma and can be created using centrifugation or gravity filtration of autologous blood. PRP is being extensively used in various regenerative medicine applications such as orthopedic surgeries for treating muscle, bone and joint injuries. The systems are equipped with advanced technologies that precisely separate platelets from other blood components through centrifugation followed by their careful compression into a concentrated formulation. They deliver safe and clinically effective volumes of autologous PRP which boost the body's natural healing abilities. With the aging global population and rise in sports injuries, the demand for less invasive platelet concentration techniques is augmenting.
The global platelet concentration systems market is driven by the rising incidence of chronic diseases, sports injuries, and trauma cases that considerably benefit from PRP therapies. The growing adoption of tissue engineering approaches in reconstructive procedures and an increasing dependence on blood-derived products for wound care are fueling the market growth. However, high costs associated with these devices and lack of reimbursement policies for PRP-based treatments in some regions can impede widespread adoption. Moreover, each system requiring regulatory clearances poses challenges for market players. The untapped opportunities lie in developing economies with large geriatric populations and in utilizing platelet concentrate for new medical applications. Ongoing R&D for improving concentration accuracy, automating the process and expanding indications are expected to create lucrative prospects over the forecast period.
Platelet Concentration Systems Market Detailed Segmentation: